Dr. Teruhisa Ueda, President & CEO of Shimadzu Corporation was awarded an honorary Doctor of Science degree by the University of Kansas

May 29, 2019  Dr. Teruhisa Ueda, President & CEO of Shimadzu Corporation was awarded an honorary Doctor of Science degree by the University of Kansas at the commencement ceremony on May 19th. The university first began awarding honorary degrees in 2012, and Dr. Ueda is the 17th recipient and the first Japanese to be awarded... Read more

Merck KGaA, Darmstadt, Germany, Announces Two New Appointments to Group Leadership Positions

28 MAY 2019 | DARMSTADT, GERMANY Tina Sandmann appointed Head of Internal Auditing Barbara Weiland to become Chief Compliance Officer Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced two new appointments to Group leadership positions that will take effect on July 1. Tina Sandmann will become Head of Internal Auditing. She will report to Stefan... Read more

Brooks to Participate in Two Upcoming Investor Conferences

CHELMSFORD, Mass., May 24, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in two upcoming investor conferences: Jefferies Global Health Care Investor Conference in New York on June 5, 2019 with a presentation at 9:00 a.m. EDT. Stifel Nicholas Cross Sector Insight Conference at the Intercontinental Hotel in Boston... Read more

Keysight Technologies Announces New Board Member

Appoints Joanne B. Olsen as a director effective immediately SANTA ROSA, Calif., May 24, 2019 Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers and governments accelerate innovation to connect and secure the world, today announced that on May 23, 2019, the Board of Directors (the “Board”) appointed Joanne B.... Read more

Tomas Blomquist – new CEO & President of Biotage

FRI, MAY 24, 2019 18:00 CET Contact persons:Torben Jörgensen, CEOTel: +46 707 49 05 84, torben.jorgensen@biotage.comThomas Eklund, Chairman of the BoardTel: +46 (0)708 24 20 25, thomas.eklund@investorab.com Uppsala, Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) – Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA... Read more

We have posted "Financial Results Presentation".

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation

Hilden, Germany and Germantown, Maryland, May 21, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON®-TB Access, a new solution under development for diagnosis of latent tuberculosis (TB) infection in low-resource regions with a high disease burden of tuberculosis, will be recognized by the Joint United Nations Programme on HIV/AIDS... Read more

Luminex Corporation Declares Second Quarter Cash Dividend

AUSTIN, Texas, May 21, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq:LMNX) (the “Company”), today announced that its board of directors declared a cash dividend for the second quarter of 2019 of $0.06 per share of common stock payable on July 11, 2019 to stockholders of record as of the close of business June 20, 2019. About Luminex CorporationAt... Read more